Insider transactions

EDGAR

Y-mAbs Therapeutics, Inc.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-20.

Open-market purchases (code P)
0 transactions, — shares
Open-market sales (code S)
0 transactions, — shares

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

This issuer has insider filings in the store, but no transaction in this window or code group.

Institutional holders (Form 13F)

No Form 13F position in this issuer is placed in the store. A holder not yet linked or not yet filed is absent, not zero.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
Beryl Capital Management LLC Common Stock00.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 1Open filing 0000935836-25-000695 Dispute this row
Beryl Capital Management LP Common Stock00.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 1Open filing 0000935836-25-000695 Dispute this row
Beryl Capital Partners II LP Common Stock00.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 1Open filing 0000935836-25-000695 Dispute this row
David A. Witkin Common Stock00.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 1Open filing 0000935836-25-000695 Dispute this row
HBM Healthcare Investments (Cayman) Ltd. Common Stock, $0.0001 par value00.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 7Open filing 0001104659-25-112490 Dispute this row
Caligan Partners LP Common stock, par value $0.0001 per share00.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 1Open filing 0000902664-25-004973 Dispute this row
David Johnson Common stock, par value $0.0001 per share00.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 1Open filing 0000902664-25-004973 Dispute this row
Paradigm BioCapital Advisors LP Common Stock, $0.0001 par value per share0.00.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 2Open filing 0001104659-25-112618 Dispute this row
Paradigm BioCapital Advisors GP LLC Common Stock, $0.0001 par value per share0.00.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 2Open filing 0001104659-25-112618 Dispute this row
Senai Asefaw, M.D. Common Stock, $0.0001 par value per share00.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 2Open filing 0001104659-25-112618 Dispute this row
Paradigm BioCapital International Fund Ltd. Common Stock, $0.0001 par value per share00.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 2Open filing 0001104659-25-112618 Dispute this row
Glazer Capital, LLC Common Stock, $0.0001 par value0.000.0009/30/2025 Filed 2025-11-13SCHEDULE 13G/AAmendment 1Open filing 0001076809-25-000139 Dispute this row
Paul J. Glazer Common Stock, $0.0001 par value0.000.0009/30/2025 Filed 2025-11-13SCHEDULE 13G/AAmendment 1Open filing 0001076809-25-000139 Dispute this row
ACORN BIOVENTURES, L.P. Common stock, par value $0.0001 per share2.61,175,686.0008/19/2025 Filed 2025-08-20SCHEDULE 13G/AAmendment 3Open filing 0001636587-25-000047 Dispute this row
ACORN CAPITAL ADVISORS GP, LLC Common stock, par value $0.0001 per share2.61,175,686.0008/19/2025 Filed 2025-08-20SCHEDULE 13G/AAmendment 3Open filing 0001636587-25-000047 Dispute this row
ACORN BIOVENTURES 2, L.P. Common stock, par value $0.0001 per share3.61,620,611.0008/19/2025 Filed 2025-08-20SCHEDULE 13G/AAmendment 3Open filing 0001636587-25-000047 Dispute this row
Acorn Capital Advisors GP 2, LLC Common stock, par value $0.0001 per share3.61,620,611.0008/19/2025 Filed 2025-08-20SCHEDULE 13G/AAmendment 3Open filing 0001636587-25-000047 Dispute this row
Anders Hove Common stock, par value $0.0001 per share6.22,796,297.0008/19/2025 Filed 2025-08-20SCHEDULE 13G/AAmendment 3Open filing 0001636587-25-000047 Dispute this row
ACORN BIOVENTURES, L.P. Common stock, par value $0.0001 per share3.01,301,686.0008/14/2025 Filed 2025-08-15SCHEDULE 13G/AAmendment 2Open filing 0001636587-25-000045 Dispute this row
ACORN CAPITAL ADVISORS GP, LLC Common stock, par value $0.0001 per share3.01,301,686.0008/14/2025 Filed 2025-08-15SCHEDULE 13G/AAmendment 2Open filing 0001636587-25-000045 Dispute this row
ACORN BIOVENTURES 2, L.P. Common stock, par value $0.0001 per share4.01,794,611.0008/14/2025 Filed 2025-08-15SCHEDULE 13G/AAmendment 2Open filing 0001636587-25-000045 Dispute this row
Acorn Capital Advisors GP 2, LLC Common stock, par value $0.0001 per share4.01,794,611.0008/14/2025 Filed 2025-08-15SCHEDULE 13G/AAmendment 2Open filing 0001636587-25-000045 Dispute this row
Anders Hove Common stock, par value $0.0001 per share7.03,096,297.0008/14/2025 Filed 2025-08-15SCHEDULE 13G/AAmendment 2Open filing 0001636587-25-000045 Dispute this row
Glazer Capital, LLC Common Stock, $0.0001 par value5.842,654,700.0008/08/2025 Filed 2025-08-15SCHEDULE 13GOpen filing 0001076809-25-000098 Dispute this row
Paul J. Glazer Common Stock, $0.0001 par value5.842,654,700.0008/08/2025 Filed 2025-08-15SCHEDULE 13GOpen filing 0001076809-25-000098 Dispute this row
Beryl Capital Management LLC Common Stock9.04,087,091.0008/05/2025 Filed 2025-08-12SCHEDULE 13GOpen filing 0000935836-25-000492 Dispute this row
Beryl Capital Management LP Common Stock9.04,087,091.0008/05/2025 Filed 2025-08-12SCHEDULE 13GOpen filing 0000935836-25-000492 Dispute this row
Beryl Capital Partners II LP Common Stock6.83,095,833.0008/05/2025 Filed 2025-08-12SCHEDULE 13GOpen filing 0000935836-25-000492 Dispute this row
David A. Witkin Common Stock9.04,087,091.0008/05/2025 Filed 2025-08-12SCHEDULE 13GOpen filing 0000935836-25-000492 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,592,621 filings read, dated 2004-06-14 to 2026-11-19: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
201517,857
2016222,642
2017222,009
2018223,345
2019216,482
2020218,850
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026262,467

Filings made before the SEC required XML are listed, not extracted.

Back to Y-mAbs Therapeutics, Inc.